State of Alaska Department of Revenue reduced its holdings in shares of Balchem Co. (NASDAQ:BCPC – Free Report) by 0.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,405 shares of the basic materials company’s stock after selling 110 shares during the period. State of Alaska Department of Revenue owned 0.06% of Balchem worth $2,999,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of the business. R Squared Ltd purchased a new position in shares of Balchem during the fourth quarter valued at approximately $29,000. Pacer Advisors Inc. increased its position in Balchem by 18.4% during the 4th quarter. Pacer Advisors Inc. now owns 1,113 shares of the basic materials company’s stock valued at $181,000 after buying an additional 173 shares in the last quarter. KBC Group NV raised its stake in Balchem by 42.5% during the fourth quarter. KBC Group NV now owns 1,275 shares of the basic materials company’s stock valued at $208,000 after buying an additional 380 shares during the last quarter. Tributary Capital Management LLC boosted its holdings in Balchem by 1.2% in the fourth quarter. Tributary Capital Management LLC now owns 136,255 shares of the basic materials company’s stock worth $22,209,000 after acquiring an additional 1,634 shares in the last quarter. Finally, Inspire Investing LLC grew its stake in shares of Balchem by 4.9% in the fourth quarter. Inspire Investing LLC now owns 2,462 shares of the basic materials company’s stock worth $401,000 after acquiring an additional 114 shares during the last quarter. Institutional investors own 87.91% of the company’s stock.
Balchem Stock Performance
Shares of BCPC opened at $160.28 on Monday. The company has a market cap of $5.21 billion, a price-to-earnings ratio of 43.09, a P/E/G ratio of 4.42 and a beta of 0.69. The business’s fifty day simple moving average is $165.18 and its two-hundred day simple moving average is $170.14. Balchem Co. has a 12 month low of $137.69 and a 12 month high of $186.03. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.
Balchem Increases Dividend
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on BCPC. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th. HC Wainwright lifted their target price on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th.
Read Our Latest Stock Report on Balchem
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Further Reading
- Five stocks we like better than Balchem
- Transportation Stocks Investing
- 3 Volatility ETFs to Help You Profit from Market Chaos
- What Does Downgrade Mean in Investing?
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.